Breast cancer risks in individuals testing negative for a known family mutation in BRCA1 or BRCA2

Breast Cancer Research and Treatment

Volumn 119, Issue 2, 2010, Pages 409-414

  Domchek, S M ^a,b   Gaudet, M M ^c   Stopfer, J E ^a   Fleischaut, M H ^c   Powers, J ^a   Kauff, N ^c   Offit, K ^c   Nathanson, K L ^a,b   Robson, M ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

BRCA1; BRCA2; Breast cancer; Phenocopy

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CASE REPORT; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MASTECTOMY; OVARY CANCER; PRIORITY JOURNAL; STANDARDIZED INCIDENCE RATIO; UNITED STATES;

ADULT; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GUIDELINE ADHERENCE; HUMANS; INCIDENCE; MIDDLE AGED; MUTATION; NEOPLASM INVASIVENESS; PEDIGREE; PHENOTYPE; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; UNITED STATES;

EID: 74849110212     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0611-y     Document Type: Article

References (20)

1. TR Rebbeck HT Lynch SL Neuhausen SA Narod L Van't Veer JE Garber G Evans C Isaacs MB Daly E Matloff, et al. 2002 Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations N Engl J Med 346 21 1616 1622 10.1056/NEJMoa012158 12023993 (Pubitemid 34755669)
2. ND Kauff JM Satagopan ME Robson L Scheuer M Hensley CA Hudis NA Ellis J Boyd PI Borgen RR Barakat, et al. 2002 Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation N Engl J Med 346 21 1609 1615 10.1056/NEJMoa020119 12023992 (Pubitemid 34755668)
3. SM Domchek TM Friebel SL Neuhausen T Wagner G Evans C Isaacs JE Garber MB Daly R Eeles E Matloff, et al. 2006 Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study Lancet Oncol 7 3 223 229 10.1016/S1470-2045(06)70585-X 1:CAS:528:DC%2BD28XitVeitLs%3D 16510331 (Pubitemid 43286452)
4. TR Rebbeck T Friebel HT Lynch SL Neuhausen L van 't Veer JE Garber GR Evans SA Narod C Isaacs E Matloff, et al. 2004 Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group J Clin Oncol 22 6 1055 1062 10.1200/JCO.2004.04.188 14981104 Epub 2004 Feb 1023 (Pubitemid 41095038)
5. H Meijers-Heijboer B van Geel WL van Putten SC Henzen-Logmans C Seynaeve MB Menke-Pluymers CC Bartels LC Verhoog AM van den Ouweland MF Niermeijer, et al. 2001 Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation N Engl J Med 345 3 159 164 10.1056/NEJM200107193450301 1:CAS:528:DC%2BD3MXlslSlt7g%3D 11463009 (Pubitemid 32662123)
6. E Warner DB Plewes KA Hill PA Causer JT Zubovits RA Jong MR Cutrara G DeBoer MJ Yaffe SJ Messner, et al. 2004 Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination JAMA 292 11 1317 1325 10.1001/jama.292.11.1317 1:CAS:528:DC%2BD2cXns12rs78%3D 15367553 (Pubitemid 39223222)
7. MO Leach CR Boggis AK Dixon DF Easton RA Eeles DG Evans FJ Gilbert I Griebsch RJ Hoff P Kessar, et al. 2005 Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) Lancet 365 9473 1769 1778 10.1016/S0140-6736(05)66481-1 1:STN:280:DC%2BD2M3mvFCqtg%3D%3D 15910949 (Pubitemid 40744657)
8. A Antoniou PD Pharoah S Narod HA Risch JE Eyfjord JL Hopper N Loman H Olsson O Johannsson A Borg, et al. 2003 Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 5 1117 1130 10.1086/375033 1:CAS:528:DC%2BD3sXjslagtbg%3D 12677558 (Pubitemid 36530000)
9. MC King JH Marks JB Mandell 2003 Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 Science 302 5645 643 646 10.1126/science.1088759 1:CAS:528:DC%2BD3sXotlWqt7Y%3D 14576434 (Pubitemid 37310920)
10. A Smith A Moran MC Boyd M Bulman A Shenton L Smith R Iddenden ER Woodward F Lalloo ER Maher, et al. 2007 Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening J Med Genet 44 1 10 15 10.1136/jmg.2006.043091 1:CAS:528:DC%2BD2sXhvVGisro%3D 17079251 (Pubitemid 46142833)
11. J Gronwald C Cybulski J Lubinski SA Narod 2007 Phenocopies in breast cancer 1 (BRCA1) families: implications for genetic counselling J Med Genet 44 4 e76 10.1136/jmg.2006.048462 17400795
12. Rowan E, Poll A, Narod SA (2007) A prospective study of breast cancer risk in relatives of BRCA1/BRCA2 mutation carriers. J Med Genet 44(8):e89 (author reply e88)
13. AC Antoniou OM Sinilnikova J Simard M Leone M Dumont SL Neuhausen JP Struewing D Stoppa-Lyonnet L Barjhoux DJ Hughes, et al. 2007 RAD51 135G->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies Am J Hum Genet 81 6 1186 1200 10.1086/522611 1:CAS:528:DC%2BD2sXhtl2ju77P 17999359 (Pubitemid 350211449)
14. Goldgar D, Venne V, Conner T, Buys S (2007) BRCA phenocopies or ascertainment bias? J Med Genet 44(8):e86 (author reply e88)
15. CB Begg RW Haile A Borg KE Malone P Concannon DC Thomas B Langholz L Bernstein JH Olsen CF Lynch, et al. 2008 Variation of breast cancer risk among BRCA1/2 carriers JAMA 299 2 194 201 10.1001/jama.2007.55-a 1:CAS:528: DC%2BD1cXlslOrsg%3D%3D 18182601
16. SA Gayther J Mangion P Russell S Seal R Barfoot BA Ponder MR Stratton D Easton 1997 Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene Nat Genet 15 1 103 105 10.1038/ng0197-103 1:CAS:528:DyaK2sXjsFKjsQ%3D%3D 8988179 (Pubitemid 27014960)
17. AC Antoniou AB Spurdle OM Sinilnikova S Healey KA Pooley RK Schmutzler B Versmold C Engel A Meindl N Arnold, et al. 2008 Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers Am J Hum Genet 82 4 937 948 10.1016/j.ajhg.2008.02. 008 1:CAS:528:DC%2BD1cXltVKrsbc%3D 18355772
18. Antoniou AC, Sinilnikova OM, McGuffog L, Healey S, Nevanlinna H, Heikkinen T, Simard J, Spurdle AB, Beesley J, Chen X et al (2009) Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet 18(22):4442-4456
19. KA Schneider LM DiGianni AF Patenaude N Klar JE Stopfer KA Calzone FP Li BL Weber JE Garber 2004 Accuracy of cancer family histories: comparison of two breast cancer syndromes Genet Test 8 3 222 228 10.1089/gte.2004.8.222 15727243
20. DG Evans A Howell 2007 Breast cancer risk-assessment models Breast Cancer Res 9 5 213 10.1186/bcr1750 17888188